Indiana University

Breakthrough Gene Therapy Treats Hemophilia B

views 1178
Air date: March 18, 2012

Host: David Crabb, MD

Men's & Women's Health Patient Care Pediatrics Research
Email Email
Share Sound Medicine Share this segment
MP3 download Download MP3

Interview: Katherine A. High, MD,
professor of pediatrics, University of Pennsylvania School of Medicine
director, Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia
Investigator, Howard Hughes Medical Institute



Hemophilia is a genetic disorder in which the patient’s blood lacks the all-important clotting factor.

Physician and hemophilia researcher Katherine A. High, MD, chats with Sound Medicine’s Dr. David Crabb about the encouraging results of a recent study that injected patients with the correct form of the defective gene.

It may be the first instance of gene therapy successfully used to treat a well-known disease.

Dr. High is a professor of pediatrics at the University of Pennsylvania School of Medicine and director of the Center for Cellular and Molecular Therapeutics at Children's Hospital of Philadelphia. In addition, she is an investigator with Howard Hughes Medical Institute.

Find us on:

Sound Medicine facebook fan page Follow Sound Medicine on twitter

Listen to us free at:

Sound Medicine on Stitcher

Promo code: Sound